CBD and CBG Alter Melanoma Cell Membranes in Ways That Could Aid Cancer Treatment
CBD and CBG modified melanoma cell membrane composition, lipid signaling, and cannabinoid receptor expression — effects enhanced by UVA radiation, suggesting potential for integrative melanoma therapy.
Quick Facts
What This Study Found
CBD (5 µM) and CBG (1 µM) altered melanoma cell membrane phospholipid fatty acids, sialic acid, surface charge, and lipid rafts; increased endocannabinoid 2-AG levels; and when combined, reduced pro-inflammatory eicosanoids and modified cannabinoid receptor expression after UVA irradiation.
Key Numbers
CBD at 5 µM, CBG at 1 µM; UVA dose 18 J/cm²; combined CBD/CBG reduced pro-inflammatory eicosanoids; significant 2-AG increase with phytocannabinoid treatment; altered CB1/CB2/TRPV1/PPARγ expression.
How They Did This
In vitro study of CBD and CBG effects on SK-MEL-5 melanoma cells, analyzing membrane composition, lipolytic enzyme activity, lipid mediators, and receptor expression with and without UVA irradiation.
Why This Research Matters
Melanoma has high metastatic potential and poor prognosis in advanced stages — finding that phytocannabinoids target cell membrane structures important for metastasis opens a novel therapeutic angle.
The Bigger Picture
Cell membranes are increasingly recognized as therapeutic targets in cancer — phytocannabinoids' ability to remodel membrane composition and lipid signaling adds a mechanistic dimension to their anticancer potential.
What This Study Doesn't Tell Us
Single cell line in vitro; concentrations may not be achievable in vivo; UVA irradiation model may not reflect all melanoma contexts; no cell viability or tumor growth data.
Questions This Raises
- ?Can membrane-targeted phytocannabinoid effects translate to anti-metastatic outcomes in vivo?
- ?Would these effects occur in other melanoma cell lines or cancer types?
Trust & Context
- Key Stat:
- Evidence Grade:
- Detailed mechanistic in vitro study with comprehensive lipid analysis, but single cell line and no functional anti-cancer endpoints measured.
- Study Age:
- Published in 2026, contributing to the growing understanding of phytocannabinoid anti-cancer mechanisms.
- Original Title:
- Phytocannabinoids influence phospholipid metabolism of melanoma cells: Modulation of in vitro effects of the UVA irradiation.
- Published In:
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 195, 119003 (2026)
- Authors:
- Biernacki, Michał(3), Sękowski, Szymon, Dobrzyńska, Izabela, Olchowik-Grabarek, Ewa, Zarkovic, Neven, Jarocka-Karpowicz, Iwona, Gęgotek, Agnieszka, Skrzydlewska, Elżbieta
- Database ID:
- RTHC-08121
Evidence Hierarchy
Frequently Asked Questions
Can cannabinoids help treat melanoma?
This lab study found CBD and CBG alter melanoma cell membranes and lipid signaling in ways that could be therapeutically useful, but this is very early research with no clinical data yet.
What is CBG?
Cannabigerol (CBG) is a minor cannabinoid found in cannabis that, like CBD, is non-psychoactive. This study used it at just 1 µM alongside CBD to alter melanoma cell behavior.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08121APA
Biernacki, Michał; Sękowski, Szymon; Dobrzyńska, Izabela; Olchowik-Grabarek, Ewa; Zarkovic, Neven; Jarocka-Karpowicz, Iwona; Gęgotek, Agnieszka; Skrzydlewska, Elżbieta. (2026). Phytocannabinoids influence phospholipid metabolism of melanoma cells: Modulation of in vitro effects of the UVA irradiation.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 195, 119003. https://doi.org/10.1016/j.biopha.2026.119003
MLA
Biernacki, Michał, et al. "Phytocannabinoids influence phospholipid metabolism of melanoma cells: Modulation of in vitro effects of the UVA irradiation.." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026. https://doi.org/10.1016/j.biopha.2026.119003
RethinkTHC
RethinkTHC Research Database. "Phytocannabinoids influence phospholipid metabolism of melan..." RTHC-08121. Retrieved from https://rethinkthc.com/research/biernacki-2026-phytocannabinoids-influence-phospholipid-metabolism
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.